Skip to main navigationSkip to main content
The University of Southampton
Southampton Health Technology Assessments Centre

Hepatitis C

Click on the title for more information (where available).

Kalita, N., Harris, P., Cooper, K., Onyimadu, O., Picot, J. Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C. Southampton Health Technology Assessments Centre (SHTAC), 2017

Jones J, Pickett K, Chorozogolou M, Colquitt JL, Picot J. Ombitasvir/paritaprevir/ritonavir with or without dasabuvir for treating chronic hepatitis C: A Single Technology Appraisal. Southampton Health Technology Assessments Centre, 2015.

Cooper K, Picot J, Shepherd J, Frampton G, Colquitt J. Simeprevir for treating genotype 1 or 4 chronic hepatitis C: A Single Technology Appraisal. Southampton Health Technology Assessments Centre, 2014.

Copley V, Frampton G, Pickett K, Loveman E, Cooper K. Sofosbuvir for treating chronic hepatitis C. 2014

Hartwell, D., Cooper, K., Frampton, G.K., Baxter, L. and Loveman, E. The clinical and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people. Health Technology Assessment 2014; 18(65).

Cooper K, Baxter L, Loveman E, Hartwell D, and Frampton G. The cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people. ISPOR 16th Annual European Congress. ISPOR 16th Annual European Congress, Dublin, Ireland. 2013.

Hartwell D, Jones J, Louise B, Shepherd J. Systematic review of shortened peginterferon and ribavirin treatment of hepatitis C.  International Journal of Technology Assessment in Health Care 2012;28 (4).

Mendes D, White K, Cooper K, Bryant J. Boceprevir for the treatment of genotype 1 chronic hepatitis C. A Single Technology Appraisal. Southampton Health Technology Assessments Centre, 2011.

Jeremy J, Hartwell D, Baxter L, Harris P.  Telaprevir for the treatment of genotype 1 chronic hepatitis C. A Single Technology Appraisal. Southampton Health Technology Assessments Centre, 2011.

Hartwell D, Jones J, Baxter L, Shepherd J. Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation. Health Technology Assessment 2011;15 (17).

Hartwell D, Shepherd J. Pegylated and non-pegylated interferon-alfa and ribavirin for the treatment of mild chronic hepatitis C: A systematic review and meta-analysis. International Journal of Technology Assessment in Health Care 2009;25(1):56-62.  

Shepherd J, Jones J, Hartwell D, Davidson P, Price A, Waugh N. Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C - a systematic review and economic evaluation. Health Technology Assessment 2007;11(11).  

Shepherd J, Jones J. A systematic review of the cost-effectiveness of peginterferon alfa-2b in the treatment of chronic hepatitis C. Expert Review of Pharmacoeconomics & Outcomes Research 2007;7(6).

Hartwell D, Shepherd J, Jones J, Davidson P, and Price A. Pegylated and non-pegylated interferon alfa and ribavirin for the treatment of mild chronic hepatitis C - a systematic review (poster presentation). HTAi 2006 (July 2006, Adelaide).  2006. 

Jones J, Hartwell D, Shepherd J, Davidson P, Price A, and Waugh N. Early anti-viral treatment versus watchful waiting for chronic hepatitis c: an economic evaluation. HTAi Annual Meeting.  2006.

Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J. Clinical and cost-effectiveness of pegylated interferon alfa in the treatment of chronic hepatitis C: a systematic review and economic evaluation. International Journal of Technology Assessment in Health Care 2005;21(1):47-54.  

Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J. Pegylated interferon alpha 2a and 2b in combination with ribavirin in the treatment of chronic hepatitis C : a systematic review. Health Technology Assessment 2004;8(39).  

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×